26 min listen
Episode 29: Triglycerides in Cardiovascular Disease Prevention Part 1
FromAACE Podcasts
ratings:
Length:
15 minutes
Released:
Jul 8, 2022
Format:
Podcast episode
Description
The landmark Reduction of Cardiovascular Events with Icosapent Ethyl–Intervention Trial (REDUCE-IT®) was a global outcomes study designed to assess the cardioprotective efficacy and safety of VASCEPA® (icosapent ethyl) as an add-on to statin therapy in reducing major cardiovascular (CV) events in a high-risk patient population. Join endocrine experts Eliot A. Brinton, MD, FAHA, FNLA, FACE, President of Utah Lipid Center, and Past President, of the American Board of Clinical Lipidology, and Betul Hatipoglu MD, Professor of Medicine at CWRU School of Medicine, and Medical Director for Diabetes & Obesity Center at University Hospital Cleveland Medical Center, to learn about the results of the REDUCE-IT® trial and new developments in CV prevention.
Released:
Jul 8, 2022
Format:
Podcast episode
Titles in the series (48)
Episode 4: 2020 ACRO by AACE Podcasts